会員登録
ログイン
【4527】ロート製薬
目薬(一般用医薬品)
業績予想修正履歴
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024.03 | 2024/02/09 | Q3予 | 272,000 | ↑ | +0.7% | +5.0% | 40,000 | ↑ | +3.9% | +14.3% | 41,500 | ↑ | +3.8% | +15.3% | 30,000 | ↑ | +3.4% | +13.2% |
| 2024.03 | 2023/11/10 | Q2予 | 270,000 | ↑ | +2.7% | +4.2% | 38,500 | ↑ | +4.1% | +10.0% | 40,000 | ↑ | +5.3% | +11.1% | 29,000 | ↑ | +5.5% | +9.4% |
| 2024.03 | 2023/08/09 | Q1予 | 263,000 | ↑ | +1.5% | +1.5% | 37,000 | ↑ | +5.7% | +5.7% | 38,000 | ↑ | +5.6% | +5.6% | 27,500 | ↑ | +3.8% | +3.8% |
| 2024.03 | 2023/05/12 | 当初予 | 259,000 | - | - | - | 35,000 | - | - | - | 36,000 | - | - | - | 26,500 | - | - | - |
| 2023.03 | 2023/05/12 | 実 | 238,664 | ↑ | +1.1% | +9.5% | 33,959 | ↑ | +2.9% | +21.3% | 35,568 | ↑ | +7.8% | +27.0% | 26,377 | ↑ | +9.9% | +35.3% |
| 2023.03 | 2023/02/13 | Q3予 | 236,000 | ↑ | +2.6% | +8.3% | 33,000 | ↑ | +6.5% | +17.9% | 33,000 | ↑ | +3.1% | +17.9% | 24,000 | ↑ | +9.1% | +23.1% |
| 2023.03 | 2022/11/10 | Q2予 | 230,000 | ↑ | +2.2% | +5.5% | 31,000 | ↑ | +3.3% | +10.7% | 32,000 | ↑ | +3.2% | +14.3% | 22,000 | ↑ | +2.3% | +12.8% |
| 2023.03 | 2022/08/09 | Q1予 | 225,000 | ↑ | +3.2% | +3.2% | 30,000 | ↑ | +7.1% | +7.1% | 31,000 | ↑ | +10.7% | +10.7% | 21,500 | ↑ | +10.3% | +10.3% |
| 2023.03 | 2022/05/12 | 当初予 | 218,000 | - | - | - | 28,000 | - | - | - | 28,000 | - | - | - | 19,500 | - | - | - |
| 2022.03 | 2022/05/12 | 実 | 199,646 | ↑ | +2.4% | +9.7% | 29,349 | ↑ | +4.8% | +27.1% | 29,084 | ↑ | +3.9% | +21.7% | 21,018 | ↑ | +7.8% | +22.9% |
| 2022.03 | 2022/02/10 | Q3予 | 195,000 | ↑ | +2.6% | +7.1% | 28,000 | ↑ | +12.0% | +21.2% | 28,000 | ↑ | +12.0% | +17.2% | 19,500 | ↑ | +8.3% | +14.0% |
| 2022.03 | 2021/11/11 | Q2予 | 190,000 | ↑ | +4.4% | +4.4% | 25,000 | ↑ | +8.2% | +8.2% | 25,000 | ↑ | +4.6% | +4.6% | 18,000 | ↑ | +5.3% | +5.3% |
| 2022.03 | 2021/08/10 | Q1予 | 182,000 | → | 0.0% | 0.0% | 23,100 | → | 0.0% | 0.0% | 23,900 | → | 0.0% | 0.0% | 17,100 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/12 | 当初予 | 182,000 | - | - | - | 23,100 | - | - | - | 23,900 | - | - | - | 17,100 | - | - | - |
| 2021.03 | 2021/05/12 | 実 | 181,287 | ↓ | -0.9% | -0.9% | 22,990 | ↑ | +5.5% | +5.5% | 23,910 | ↑ | +8.2% | +8.2% | 16,743 | ↑ | +19.6% | +19.6% |
| 2021.03 | 2021/02/10 | Q3予 | 183,000 | → | 0.0% | 0.0% | 21,800 | → | 0.0% | 0.0% | 22,100 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
| 2021.03 | 2020/11/12 | Q2予 | 183,000 | → | 0.0% | 0.0% | 21,800 | → | 0.0% | 0.0% | 22,100 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
| 2021.03 | 2020/08/11 | Q1予 | 183,000 | → | 0.0% | 0.0% | 21,800 | → | 0.0% | 0.0% | 22,100 | → | 0.0% | 0.0% | 14,000 | → | 0.0% | 0.0% |
| 2021.03 | 2020/05/12 | 当初予 | 183,000 | - | - | - | 21,800 | - | - | - | 22,100 | - | - | - | 14,000 | - | - | - |
| 2020.03 | 2020/05/12 | 実 | 188,327 | ↑ | +2.4% | +2.4% | 23,085 | ↑ | +7.4% | +7.4% | 22,735 | ↑ | +6.7% | +6.7% | 15,410 | ↑ | +14.1% | +14.1% |
| 2020.03 | 2020/02/12 | Q3予 | 184,000 | → | 0.0% | 0.0% | 21,500 | → | 0.0% | 0.0% | 21,300 | → | 0.0% | 0.0% | 13,500 | → | 0.0% | 0.0% |
| 2020.03 | 2019/11/13 | Q2予 | 184,000 | → | 0.0% | 0.0% | 21,500 | → | 0.0% | 0.0% | 21,300 | → | 0.0% | 0.0% | 13,500 | → | 0.0% | 0.0% |
| 2020.03 | 2019/08/08 | Q1予 | 184,000 | → | 0.0% | 0.0% | 21,500 | → | 0.0% | 0.0% | 21,300 | → | 0.0% | 0.0% | 13,500 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/10 | 当初予 | 184,000 | - | - | - | 21,500 | - | - | - | 21,300 | - | - | - | 13,500 | - | - | - |
| 2019.03 | 2019/05/10 | 実 | 183,582 | ↑ | +0.2% | +4.3% | 20,812 | ↓ | -2.7% | +6.7% | 18,970 | ↓ | -13.0% | -3.2% | 9,799 | ↓ | -26.3% | -17.7% |
| 2019.03 | 2019/02/13 | Q3予 | 183,300 | → | 0.0% | +4.1% | 21,400 | → | 0.0% | +9.7% | 21,800 | → | 0.0% | +11.2% | 13,300 | → | 0.0% | +11.8% |
| 2019.03 | 2018/11/13 | Q2予 | 183,300 | ↑ | +4.1% | +4.1% | 21,400 | ↑ | +9.7% | +9.7% | 21,800 | ↑ | +11.2% | +11.2% | 13,300 | ↑ | +11.8% | +11.8% |
| 2019.03 | 2018/08/09 | Q1予 | 176,000 | → | 0.0% | 0.0% | 19,500 | → | 0.0% | 0.0% | 19,600 | → | 0.0% | 0.0% | 11,900 | → | 0.0% | 0.0% |
| 2019.03 | 2018/05/11 | 当初予 | 176,000 | - | - | - | 19,500 | - | - | - | 19,600 | - | - | - | 11,900 | - | - | - |
| 2018.03 | 2018/05/11 | 実 | 171,742 | ↑ | +4.1% | +8.4% | 19,087 | ↑ | +13.6% | +22.4% | 18,849 | ↑ | +11.5% | +17.8% | 9,289 | ↓ | -11.5% | -8.9% |
| 2018.03 | 2018/02/09 | Q3予 | 165,000 | → | 0.0% | +4.1% | 16,800 | → | 0.0% | +7.7% | 16,900 | → | 0.0% | +5.6% | 10,500 | → | 0.0% | +2.9% |
| 2018.03 | 2017/11/10 | Q2予 | 165,000 | → | 0.0% | +4.1% | 16,800 | → | 0.0% | +7.7% | 16,900 | → | 0.0% | +5.6% | 10,500 | → | 0.0% | +2.9% |
| 2018.03 | 2017/11/02 | 修正予 | 165,000 | ↑ | +4.1% | +4.1% | 16,800 | ↑ | +7.7% | +7.7% | 16,900 | ↑ | +5.6% | +5.6% | 10,500 | ↑ | +2.9% | +2.9% |
| 2018.03 | 2017/08/08 | Q1予 | 158,500 | → | 0.0% | 0.0% | 15,600 | → | 0.0% | 0.0% | 16,000 | → | 0.0% | 0.0% | 10,200 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/11 | 当初予 | 158,500 | - | - | - | 15,600 | - | - | - | 16,000 | - | - | - | 10,200 | - | - | - |
| 2017.03 | 2017/05/11 | 実 | 154,599 | ↓ | 0.0% | -5.2% | 15,451 | ↓ | -0.3% | -0.3% | 15,964 | ↑ | +3.0% | +5.0% | 10,011 | ↑ | +0.1% | +5.4% |
| 2017.03 | 2017/04/28 | 修正予 | 154,600 | ↑ | +2.7% | -5.2% | 15,500 | ↑ | +18.3% | 0.0% | 15,500 | ↑ | +15.7% | +2.0% | 10,000 | ↑ | +33.3% | +5.3% |
| 2017.03 | 2017/02/08 | Q3予 | 150,500 | → | 0.0% | -7.7% | 13,100 | → | 0.0% | -15.5% | 13,400 | → | 0.0% | -11.8% | 7,500 | → | 0.0% | -21.1% |
| 2017.03 | 2016/11/11 | Q2予 | 150,500 | ↓ | -7.7% | -7.7% | 13,100 | ↓ | -15.5% | -15.5% | 13,400 | ↓ | -11.8% | -11.8% | 7,500 | ↓ | -21.1% | -21.1% |
| 2017.03 | 2016/05/13 | 当初予 | 163,000 | - | - | - | 15,500 | - | - | - | 15,200 | - | - | - | 9,500 | - | - | - |
| 2016.03 | 2016/05/13 | 実 | 167,016 | ↓ | -0.3% | +1.8% | 15,683 | ↑ | +3.9% | +14.5% | 15,339 | ↑ | +1.6% | +8.8% | 9,098 | ↓ | -4.2% | +3.4% |
| 2016.03 | 2016/02/09 | Q3予 | 167,500 | → | 0.0% | +2.1% | 15,100 | → | 0.0% | +10.2% | 15,100 | → | 0.0% | +7.1% | 9,500 | → | 0.0% | +8.0% |
| 2016.03 | 2015/11/11 | Q2予 | 167,500 | → | 0.0% | +2.1% | 15,100 | → | 0.0% | +10.2% | 15,100 | → | 0.0% | +7.1% | 9,500 | → | 0.0% | +8.0% |
| 2016.03 | 2015/11/04 | 修正予 | 167,500 | ↑ | +2.1% | +2.1% | 15,100 | ↑ | +10.2% | +10.2% | 15,100 | ↑ | +7.1% | +7.1% | 9,500 | ↑ | +8.0% | +8.0% |
| 2016.03 | 2015/08/06 | Q1予 | 164,000 | → | 0.0% | 0.0% | 13,700 | → | 0.0% | 0.0% | 14,100 | → | 0.0% | 0.0% | 8,800 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/14 | 当初予 | 164,000 | - | - | - | 13,700 | - | - | - | 14,100 | - | - | - | 8,800 | - | - | - |
| 2015.03 | 2015/05/14 | 実 | 151,774 | ↓ | -0.1% | -0.1% | 13,159 | ↓ | -6.0% | -22.6% | 14,098 | ↓ | -2.8% | -18.0% | 8,631 | ↓ | -4.1% | -18.6% |
| 2015.03 | 2015/02/06 | Q3予 | 152,000 | → | 0.0% | 0.0% | 14,000 | ↓ | -9.7% | -17.6% | 14,500 | ↓ | -9.4% | -15.7% | 9,000 | ↓ | -10.0% | -15.1% |
| 2015.03 | 2014/11/11 | Q2予 | 152,000 | → | 0.0% | 0.0% | 15,500 | ↓ | -8.8% | -8.8% | 16,000 | ↓ | -3.0% | -7.0% | 10,000 | ↓ | -1.0% | -5.7% |
| 2015.03 | 2014/08/07 | Q1予 | 152,000 | → | 0.0% | 0.0% | - | - | - | - | 16,500 | ↓ | -4.1% | -4.1% | 10,100 | ↓ | -4.7% | -4.7% |
| 2015.03 | 2014/05/14 | 当初予 | 152,000 | - | - | - | 17,000 | - | - | - | 17,200 | - | - | - | 10,600 | - | - | - |
| 2014.03 | 2014/05/14 | 実 | 143,822 | ↑ | +0.0% | +0.0% | 16,821 | ↑ | +0.1% | +0.1% | 17,100 | → | 0.0% | 0.0% | 8,947 | ↓ | -0.6% | -0.6% |
| 2014.03 | 2014/05/12 | 当初予 | 143,800 | - | - | - | 16,800 | - | - | - | 17,100 | - | - | - | 9,000 | - | - | - |
